Skyline Medical Comments on Recent Share Price Volatility
Mar 07, 2016 12:00 pm UTC| Business
MINNEAPOLIS, March 07, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN) today announced that it has initiated an investigation into possible manipulation of its stock price, following a recent period of share price...
Kratos Selected as TT&C Modem Provider by Strategic South Asian Space Agency
Mar 07, 2016 12:00 pm UTC| Business
SAN DIEGO, March 07, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today announced that it was awarded a contract for the sale of 15 TTC integrated...
MediWound to Present at the 36th Annual Cowen Health Care Conference
Mar 07, 2016 12:00 pm UTC| Business
YAVNE, Israel, March 07, 2016 -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announces that...
Superior Uniform Group, Inc. to Present at the 28th Annual ROTH Growth Stock Conference
Mar 07, 2016 12:00 pm UTC| Business
SEMINOLE, Fla., March 07, 2016 -- Superior Uniform Group, Inc. (NASDAQ:SGC), manufacturer of uniforms, career apparel and accessories, today announced that Michael Benstock, Chief Executive Officer, and Andrew D....
Karyopharm to Report Fourth Quarter and Full Year 2015 Financial Results on March 14, 2016
Mar 07, 2016 12:00 pm UTC| Business
NEWTON, Mass., March 07, 2016 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, announced today that it will report fourth quarter and full year 2015 financial results and provide a...
PRA Group to Present at the Raymond James 37th Annual Institutional Investors Conference
Mar 07, 2016 12:00 pm UTC| Business
NORFOLK, Va., March 07, 2016 -- PRA Group (Nasdaq:PRAA), a global leader in acquiring and collecting nonperforming loans, will present to investors attending the Raymond James 37th Annual Institutional Investors...
Zynerba Pharmaceuticals to Present at 28th Annual ROTH Conference
Mar 07, 2016 12:00 pm UTC| Business
DEVON, Pa., March 07, 2016 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that...